Gabapentin Tablet, Film Coated
Product Images NDC 71205-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This formula calculates the estimated creatinine clearance (CLOr) of a patient based on their age, weight, and serum creatinine level. The formula includes a correction factor for female patients, as indicated by the multiplication by 0.85.*
FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
This appears to be a chart or a table related to a 4 week study on the effects of Gabapentin on pain scores. The study seems to have separated participants into three groups- one group was given a placebo, the other two groups were given different doses of Gabapentin per day (1800mg or 2400mg). The chart seems to track the mean pain score at various periods during the study (baseline, weeks 1-7).*
FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
This text describes a figure showing the proportion of patients who responded to treatment for controlled postherpetic neuralgia studies. The results are presented for two studies and are displayed graphically. The figure also includes statistical significance indicated by p-value being less than 0.001. The last line of the text indicates dosages of medication used in the studies, GBP 800 and GBP 2400.*
FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

FDA Label Image

71205-160-60 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 07)

71205-160-60 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 07)
This is a description of a Gabapentin medication that comes in a bottle containing 60 film-coated tablets, each containing 800mg of Gabapentin. The tablets are oval-shaped, white to off-white, and are debossed with "NT* and *151" on one side, with deep scoring on both sides. The medication has been packaged and distributed by Proficient Rx LP in California, while the manufacturer is Mis STRIDES SHASUN LIMITED, UNIT-Il R $.No. 32.33 & 34, PIMS Road, Periyakalapet, Puducherry-605 014, India. The product code is QG016060, and it should be stored at a temperature range of 20°-25°C (68°-77°F) and kept away from children. The medication guide is also included and should be given to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.